Leaflet LUIVAC 3mg tablets
Indicated for: prevention of recurrent respiratory infections
Route of administration: oral
Substance: biological products (bacterial lysates) (immunomodulator)
ATC: L03AXN1 (Antineoplastic and immunomodulating agents | Immunostimulants | Other immunostimulants)
Avoid live vaccines during treatment if contraindicated.
This medicine may increase the risk of infections.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Biological products based on bacterial lysates are used to stimulate the immune system in the prevention and treatment of recurrent respiratory infections. They contain fragments of inactivated bacteria that stimulate the body's immune response.
The product is administered orally, usually in the form of capsules or tablets, as directed by the doctor. It is important to follow the treatment regimen to achieve maximum benefits.
Side effects may include nausea, abdominal discomfort, or, in rare cases, allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of biological products based on bacterial lysates.
General data about LUIVAC 3mg
- Substance: biological products (bacterial lysates)
- Date of latest medicines list: 01-10-2024
- Product code: W64346001
- Concentration: 3mg
- Pharmaceutical form: tablets
- Quantity: 28
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.